Reuters US Business

(Reuters) -Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment candidate to its portfolio. Reuters first reported on Monday that Switzerland-based Novartis was in advanced talks to acquire MorphoSys, leading to the German biotech firm’s shares surging …

Novartis to acquire cancer-focused MorphoSys for $2.9 billion Read More »

(Reuters) – Deutsche Bank no longer expect the U.S. economy to tip into recession this year, given cooling inflation and the labor market returning to a “better balance” without unemployment rising significantly. The brokerage earlier expected the economy to enter a mild recession as the Federal Reserve tightened interest rates to tame inflation, narrowing the …

Deutsche Bank no longer expects U.S. recession in 2024 Read More »

OSLO (Reuters) – Novo Nordisk will on Tuesday begin the execution of its planned share buyback programme for 2024, the Danish maker of obesity drug Wegovy and diabetes treatment Ozempic said in a statement. Novo on Jan. 31 said it planned to carry out a share repurchase plan of up to 20 billion Danish crowns …

Novo Nordisk to begin 2024 share buybacks Read More »

By Alasdair Pal and Stella Qiu SYDNEY (Reuters) – Reserve Bank of Australia Governor Michele Bullock said on Tuesday the “Taylor Swift inflation” effect has forced some spending adjustments, including in her own children, but played down the policy impact as the pop singer prepares to arrive in the country. Swift’s Eras Tour is the …

Australia central bank shakes off ‘Taylor Swift inflation’ fears Read More »

By Arsheeya Bajwa (Reuters) -Palantir Technologies forecast a full-year profit above Wall Street estimates on strong demand for its artificial intelligence offerings, sending the data analytics company’s shares up more than 9% in extended trading. Enterprises are looking to build and deploy their own AI-backed offerings, helping demand for Palantir’s products including its Artificial Intelligence …

Palantir forecasts strong 2024 profit on robust AI demand, shares jump Read More »

By Brendan Pierson (Reuters) -A U.S. appeals court on Monday refused to dismiss a Georgia doctor’s lawsuit claiming that Bayer AG’s Roundup weedkiller caused cancer, the latest setback in the German company’s efforts to fend off thousands of similar cases carrying potentially billions of dollars in liability. A three-judge panel of the Atlanta-based 11th U.S. …

US appeals court finds Bayer not shielded from Roundup lawsuit Read More »

By David Shepardson WASHINGTON (Reuters) -The U.S. Federal Aviation Administration (FAA) on Monday said two U.S. airlines have inspected and returned to service nearly 94% of Boeing 737 MAX 9 planes following a mid-air emergency last month. The FAA lifted its grounding of MAX 9 airplanes on Jan. 24 after it halted flights following the …

FAA says 94% of Boeing 737 MAX 9 planes inspected, back in service Read More »

By Ann Saphir and Howard Schneider (Reuters) -U.S. banks anticipate an increase in demand for loans as interest rates fall this year, even as they further tighten credit standards on some types of loans, according to a Federal Reserve survey of senior bank lending officers published on Monday.  Banks cited deterioration in collateral values and …

US banks see loan demand rising in 2024, Fed survey shows Read More »